Discovering, Translating & Clinically Advancing Novel Targets, Building on Anti-Amyloid Approvals & Strengthening Endpoints, to Reinvigorate the Neurodegenerative Treatment Landscape
The approval of the first anti-amyloid drugs has resurrected the neurodegenerative disease space, opening the door for enhanced competition and innovation to develop novel disease-modifying therapies. However, as challenges remain in the clinical adoption of Lecanemab and Donanemab, the field needs to navigate the move towards disease-modifying therapeutics.
Capitalizing on the surge of innovation across new targets, lessons learned from clinical setbacks, groundbreaking progress in blood-based diagnostics, and more, the 14th Alzheimer’s & Parkinson’s Drug Development Summit returns as the only industry-focused and end-to-end meeting, with comprehensive coverage spanning early discovery through to late clinical and regulatory.
At ProMIS Neurosciences, we appreciate the size of the APDD meeting and the variety of participants. There is ample opportunity to make connections and discuss important issues among large and small groups, and large and small organizations.
Chief Scientific Officer, ProMIS Neurosciences
I am excited to discuss new targeting opportunities beyond the recently approved beta amyloid therapies with researchers and industry experts in the field.
Chief Executive Officer, Acelot
Outstanding talks and panel discussions paired with exceptional networking opportunities.
Senior Vice President, Lysoway Therapeutics
Explore the Full Event Guide
- 2 deep dive workshops into in vivo and in vitro modelling advancements
- Seminar day on fluid-based biomarker innovation
- 40+ expert speakers including industry leaders, academic KOLs and patient voices
- Multiple tracks of content spanning discovery, preclinical, clinical and regulatory
- 10+ hours dedicated networking time over 3 days
Official Partners
Expertise Partners
Innovation Partner
Attending Companies Include
Explore Related Events
Explore the Agenda
Hear the latest industry breakthroughs and gain exclusive regulatory insights during 3 jam-packed days of interactive workshops, roundtables, panel discussions and data driven content.
Partner With Us
Position yourself alongside other leading solution providers.
Join Biopharma Experts
Be part of the hottest conversations with like-minded attendees spanning all stages of drug development and make critical connections during our dedicated networking sessions.